Trials / Conditions / Enteric Hyperoxaluria

Enteric Hyperoxaluria

9 registered clinical trials studyying Enteric Hyperoxaluria — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Safety and Tolerability of FB-001 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria NCT05650112	Federation Bio Inc.	Phase 1
Recruiting	Gut Kidney Axis in Enteric Hyperoxaluria NCT05124886	NYU Langone Health	N/A
Completed	Safety, Tolerability, and Pharmacodynamics of SYNB8802v1 in Subjects With History of Gastric Bypass Surgery or NCT05377112	Synlogic	EARLY_Phase 1
Terminated	Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects NCT04909723	Novome Biotechnologies Inc	Phase 1 / Phase 2
Completed	Safety and Tolerability of SYNB8802 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria NCT04629170	Synlogic	Phase 1
Terminated	Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria NCT03847090	Allena Pharmaceuticals	Phase 3
Completed	Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia NCT03391804	Allena Pharmaceuticals	Phase 2
Completed	Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria NCT03456830	Allena Pharmaceuticals	Phase 3
Completed	Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria NCT00588120	Mayo Clinic	Phase 1